Concepedia

Halla W. Reinert

HW

5

Publications

222

Citations

5

H-Index

2016

Active since

Affiliations

University College London(Current)

Antikor (United Kingdom)

Stevenage Bioscience Catalyst

Imperial College London

University College London Hospitals NHS Foundation Trust

Halla W. Reinert is an author at University College London specializing in theranostics, medicine, and ophthalmology.

ORCID

Top concepts

Publications per year

2016–2018

5

Publications

5

Pre-clinical pharmacology and mechanism of action of SG3199, the pyrrolobenzodiazepine (PBD) dimer warhead component of antibody-drug conjugate (ADC) payload tesirine

John A. Hartley, Michael Flynn, John P. Bingham et al. · Scientific Reports · 2018 · 123 citations · Full text

Antitumor Activity of MEDI3726 (ADCT-401), a Pyrrolobenzodiazepine Antibody–Drug Conjugate Targeting PSMA, in Preclinical Models of Prostate Cancer

Song Cho, Francesca Zammarchi, David G. Williams et al. · Molecular Cancer Therapeutics · 2018 · 46 citations

Upregulation of mucin glycoprotein MUC1 in the progression to esophageal adenocarcinoma and therapeutic potential with a targeted photoactive antibody-drug conjugate

Mohammed A. Butt, Hayley Pye, Rehan Haidry et al. · Oncotarget · 2017 · 24 citations · Full text

A HER2 selective theranostic agent for surgical resection guidance and photodynamic therapy

Hayley Pye, M A Butt, Halla W. Reinert et al. · Photochemical & Photobiological Sciences · 2016 · 16 citations

, , +7

Using antibody directed phototherapy to target oesophageal adenocarcinoma with heterogeneous HER2 expression

Hayley Pye, Mohammed A. Butt, Laura Funnell et al. · Oncotarget · 2018 · 13 citations · Full text

Rows per page

1–5 of 5